We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Simplifying Drug Discovery With AI and Automation With Dr. Kevin Quick

Video  
Published: February 13, 2025 

At SLAS2025, the Technology Networks team spoke with Dr. Kevin Quick, VP of Platforms at Revvity, about how AI and automation are transforming drug discovery.

He discusses the challenges and opportunities in training datasets and the role of innovation teams. He also explains how scalable platforms are streamlining biomarker discovery and data-driven decision-making.


Watch the video in full to learn more!

Related Topic Pages
Lab of the Future
Artificial Intelligence and Machine Learning
Biomarkers
Automation
Advertisement
Chosen for You
ADCs.
Article

How AI and Spatial Biomarkers Are Transforming Antibody–Drug Conjugate Development
A glowing AI symbol surrounded by futuristic digital icons representing artificial intelligence, data security, cloud computing, and automation, hovering over an open human hand.
Industry Insight

AI Is Redefining the Role of the Scientist – Here’s How
A digital 3D rendering of a human face composed of glowing blue and orange particles, representing artificial intelligence and brain-computer interface technology.
Article

The Promise and Challenges of Brain–Computer Interfaces
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter